General Practice · San Juan, PR
NPI
1467446591
Since 2005
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
372 Ave Domenech
San Juan, PR, 00918
Phone (787) 250-7204
Medicare paid, 2024
$23K
227 services
Medicare patients, 2024
29
Average age 77
Drug cost, 2024
$1.8M
8,201 prescriptions
Company payments, 2025
$750
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angel L Pacheco-Rivera was code 99215 (office e&m - established), 109 times for 27 patients. In total Angel L Pacheco-Rivera billed 227 services in 8 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 109 | 27 | $126.88 | $14K |
| 99213 Office E&M - Established | Office | 60 | 19 | $70.53 | $4,232 |
| 99214 Office E&M - Established | Office | 22 | 14 | $74.75 | $1,644 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 17 | 17 | $127.90 | $2,174 |
By year: 2022 $45K for 359 services; 2023 $29K for 273 services; 2024 $23K for 227 services.
Medicare prescription drug claims, 2024
In 2024, the drug Angel L Pacheco-Rivera prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 335 prescriptions and refills. In total Angel L Pacheco-Rivera wrote 8,201 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 335 | 885 | 92 | $41K |
| Jardiance Empagliflozin | 324 | 809 | 87 | $486K |
| Atorvastatin Calcium Generic | 311 | 869 | 93 | $3,929 |
| Allopurinol Generic | 304 | 884 | 93 | $3,861 |
| Rosuvastatin Calcium Generic | 284 | 826 | 93 | $4,932 |
| Fenofibrate Fenofibrate,micronized | 256 | 758 | 79 | $12K |
| Gabapentin Generic | 251 | 718 | 74 | $4,157 |
| Valsartan Generic | 238 | 692 | 72 | $12K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 232 | 636 | 66 | $12K |
| Farxiga Dapagliflozin Propanediol | 202 | 482 | 53 | $276K |
| Metoprolol Succinate Generic | 199 | 585 | 66 | $4,296 |
| Famotidine Generic | 198 | 530 | 78 | $3,456 |
| Amlodipine Besylate Generic | 165 | 488 | 51 | $747 |
| Pantoprazole Sodium Generic | 149 | 425 | 62 | $2,450 |
| Clonazepam Generic | 149 | 153 | 32 | $946 |
Brand drugs: 1,875 claims; generic drugs: 6,262 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angel L Pacheco-Rivera $750 ($750 in general payments such as food, travel and fees) from 8 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $328.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.